diffrent analgesic in im vs iv routes
| Parameter | IM | IV |
|---|---|---|
| Onset | 10-30 min | 2-5 min |
| Peak effect | 30-60 min | 15-20 min |
| Duration | 3-5 h | 3-4 h |
| Standard dose | 10 mg/3-4 h | 2-4 mg bolus; titrate |
| Remarks | Erratic absorption; historically common | Preferred for titration; PCA gold standard |
| Parameter | IM | IV |
|---|---|---|
| Onset | 7-8 min | Immediate |
| Duration | 1-2 h | 0.5-1 h |
| Remarks | Used in pre-hospital/field settings | Standard intraoperative/ICU agent |
| Parameter | IM/SC | IV |
|---|---|---|
| Onset | ~15 min | 5 min |
| Peak effect | 30-60 min | 15-30 min |
| Duration | 4-5 h (IR) | 3-4 h |
| Equianalgesic parenteral dose | 1.5 mg/3-4 h | 1.5 mg/3-4 h |
| Adult starting dose | 0.5 mg/3-4 h | 0.2-0.5 mg bolus |
| Parameter | IM | IV |
|---|---|---|
| Equianalgesic parenteral | 100 mg/3 h | 100 mg/3 h |
| Starting dose IM | 50-100 mg/3-4 h | Not recommended as standard due to toxic metabolite |
| Special note | Historically common IM; now discouraged | Normeperidine accumulation risk; avoid in renal impairment |
Both IM and IV routes are now largely discouraged for meperidine due to its toxic metabolite normeperidine (seizure risk). It is not recommended as a first-line analgesic in either adults or pediatric patients. - Miller's Anesthesia, 10e
| Parameter | IM | IV |
|---|---|---|
| Equianalgesic parenteral | 75 mg/3-4 h | 75 mg/3-4 h |
| Notes | IM use still practiced; absorbed erratically | IV not recommended due to histamine release risk |
| Parameter | IM | IV |
|---|---|---|
| Equianalgesic dose | 100 mg | 100 mg |
| Adult dose | 50-100 mg/6 h | 50-100 mg slow IV over 15-20 min (to reduce seizure/nausea risk) |
| Notes | Moderate-pain use; available in many settings | IV must be given slowly; not recommended in pediatric patients |
| Parameter | IM | IV |
|---|---|---|
| Onset | ~15 min | Faster |
| Duration | 6 h (IM) | ~6 h |
| Mean t½ | ~2.2 h following IV 0.3 mg | Same |
| Notes | Partial mu-agonist; ceiling for respiratory depression | Used for opioid use disorder management perioperatively |
| Drug | Equianalgesic Parenteral Dose | IM Available? | IV Available? |
|---|---|---|---|
| Morphine | 10 mg | Yes | Yes |
| Hydromorphone | 1.5 mg | Yes | Yes |
| Oxymorphone | 1 mg | Yes | Yes |
| Fentanyl | ~0.1 mg (100 mcg) | Yes | Yes |
| Meperidine | 100 mg | Yes (discouraged) | Yes (discouraged) |
| Codeine | 75 mg | Yes | Avoid |
| Tramadol | 100 mg | Yes | Yes (slow) |
| Methadone | 10 mg | Yes | Yes |
| Levorphanol | 2 mg | Yes | Yes |
| Hydrocodone | Not available | No | No |
| Oxycodone | Not available | No | No |
| Drug | IM | IV |
|---|---|---|
| Ketorolac | 30-60 mg IM; widely used post-op | 15-30 mg IV; good pain relief per meta-analyses |
| Diclofenac | Available IM | Available IV; good analgesic effect in acute post-op pain |
| Ibuprofen | Not standard IM | IV ibuprofen exists but insufficient data to fully support |
| Parecoxib (COX-2) | IM formulation available | IV formulation available |
| Route | Notes |
|---|---|
| Oral | Preferred when patient can tolerate PO |
| Rectal | Alternative when oral not feasible |
| IV | Available as IV formulation; used perioperatively; onset faster than oral |
| IM | Not a standard route - acetaminophen is not available as an IM formulation |
diffrent analgesic in im vs iv routes with dilution and dosage
All doses are for adult patients unless otherwise specified. Always titrate to effect and adjust for age, renal/hepatic function, and opioid tolerance.
| Feature | IM | IV |
|---|---|---|
| Standard dose | 5-10 mg q3-4 h | 2-4 mg bolus; titrate q5-15 min |
| Pediatric dose | 0.1 mg/kg/3-4 h | 0.05-0.1 mg/kg bolus |
| Equianalgesic parenteral | 10 mg | 10 mg |
| Onset | 10-30 min | 2-5 min |
| Duration | 3-5 h | 3-4 h |
| Dilution (IV) | N/A | Dilute to 1 mg/mL in NS or D5W; give slow IV push over 4-5 min |
| PCA demand dose | - | 1 mg/bolus; lockout 5-10 min |
| Infusion (IV) | - | 1-5 mg/h (opioid-tolerant); not routinely recommended for opioid-naïve adults |
IM absorption is erratic and produces wider serum concentration variability than IV. IV PCA optimal demand dose is 1 mg morphine in opioid-naïve adults. - Miller's Anesthesia, 10e
| Feature | IM | IV |
|---|---|---|
| Standard dose | 50-100 mcg (1-2 mcg/kg) | 25-100 mcg bolus (0.5-1 mcg/kg) |
| Onset | 7-8 min | Immediate |
| Duration | 1-2 h | 30-60 min |
| Dilution (IV bolus) | N/A | May give undiluted (50 mcg/mL); slow IV push over 1-2 min |
| Infusion (IV) | - | 25-200 mcg/h; dilute in NS (typically 10 mcg/mL) |
| PCA demand dose | - | 10-20 mcg/bolus; lockout 5-10 min (Optimal: 40 mcg per Miller's, but 10-20 mcg used in practice) |
| Intraoperative | - | 1-2 mcg/kg bolus for induction adjunct |
Fentanyl's high lipophilicity makes IM absorption more reliable than morphine IM. IV duration is short (30-60 min) due to rapid redistribution. - Barash Table 55-11
| Feature | IM | IV |
|---|---|---|
| Standard dose | 1-2 mg q3-4 h | 0.2-1 mg q2-4 h |
| Pediatric dose | 0.015-0.02 mg/kg | 0.01-0.015 mg/kg |
| Equianalgesic parenteral | 1.5 mg (= 10 mg morphine) | 1.5 mg |
| Onset | ~15 min | 5 min |
| Duration | 4-5 h | 3-4 h |
| Dilution (IV) | N/A | Dilute to 0.1-1 mg/mL in NS; slow IV push over 2-3 min |
| PCA demand dose | - | 0.2-0.4 mg/bolus; lockout 5-10 min |
Approximately 5-7x more potent than morphine mg-for-mg. Good choice in renal impairment (unlike morphine, active metabolite does not significantly accumulate).
| Feature | IM | IV |
|---|---|---|
| Standard dose | 50-100 mg q3-4 h | 25-50 mg slow IV; not recommended as primary analgesic |
| Pediatric | 0.75 mg/kg (not recommended) | Not recommended |
| Equianalgesic parenteral | 100 mg (= 10 mg morphine) | 100 mg |
| Onset | 10-15 min | 2-5 min |
| Duration | 2-4 h | 2-3 h |
| Dilution (IV) | N/A | Dilute to 10 mg/mL; give over 2-5 min |
Both IM and IV routes are broadly discouraged in current practice due to accumulation of normeperidine (active toxic metabolite) causing CNS excitation, tremors, and seizures - especially in renal impairment or repeated dosing. Meperidine should not be used as a first-line analgesic in adults or children. - Miller's Anesthesia, 10e
| Feature | IM | IV |
|---|---|---|
| Standard dose | 50-100 mg q6 h | 50-100 mg q6 h |
| Max daily dose | 400 mg/day | 400 mg/day |
| Onset | 15-30 min | 5-10 min |
| Duration | 4-6 h | 4-6 h |
| Dilution (IV) | N/A | Dilute 100 mg in 100 mL NS; infuse over 15-20 min (slow infusion mandatory to reduce seizure and nausea risk) |
| Pediatric | Not recommended | Not recommended |
IV tramadol must be given as a slow infusion, never rapid bolus - risk of seizures, nausea, and cardiovascular instability with fast administration.
| Feature | IM | IV |
|---|---|---|
| Dose | 30-60 mg q4-6 h | Avoid IV route |
| Equianalgesic parenteral | 75 mg (= 10 mg morphine) | - |
| Onset IM | 15-30 min | - |
| Duration | 4-6 h | - |
IV codeine is contraindicated due to significant histamine release causing bronchospasm, hypotension, and cardiovascular instability. IM is used but codeine is increasingly avoided entirely given its prodrug status (requires CYP2D6 conversion to morphine - poor metabolizers get no analgesia; ultra-rapid metabolizers risk toxicity). - Barash Table 55-11
| Feature | IM | IV |
|---|---|---|
| Standard dose | 0.3 mg q6-8 h | 0.3 mg q6-8 h |
| Onset | ~15 min | Faster onset |
| Duration | 6 h | 6 h |
| Dilution (IV) | N/A | May dilute in NS; give slow IV over 2 min |
| t½ | 2.2 h (after IV 0.3 mg) | Same |
Partial mu-agonist with ceiling for respiratory depression. Multiple formulations: IV, IM, SC, buccal, intranasal, transdermal. - Barash Table 55-11
| Feature | IM | IV |
|---|---|---|
| Equianalgesic dose | 1 mg (= 10 mg morphine) | 1 mg |
| Starting dose adult | 1 mg q3-4 h | 0.5 mg slow IV |
| Feature | IM | IV |
|---|---|---|
| Equianalgesic dose | 10 mg | 10 mg |
| Starting dose adult | 2.5-5 mg q8-12 h | Use with extreme caution; specialist supervision only |
| Duration | Variable (long: 24-36 h) | Same |
Long and unpredictable half-life. QTc prolongation risk. IV use requires specialist supervision. - Goodman & Gilman Table 23-2
| Drug | Equianalgesic Oral | Equianalgesic Parenteral (IM=IV=SC) |
|---|---|---|
| Morphine | 30 mg | 10 mg |
| Hydromorphone | 6 mg | 1.5 mg |
| Oxymorphone | 10 mg | 1 mg |
| Oxycodone | 20 mg | Not available parenterally |
| Meperidine | 300 mg | 100 mg |
| Codeine | 130 mg | 75 mg |
| Tramadol | 100 mg | 100 mg |
| Methadone | 100 mg | 10 mg |
| Levorphanol | 4 mg | 2 mg |
| Fentanyl (transdermal 72h patch 25 mcg/h) | = morphine 50 mg/24 h | ~0.1 mg (100 mcg) IV/IM |
| Feature | IM | IV |
|---|---|---|
| Adult loading dose | 60 mg (single dose) | 30 mg |
| Adult maintenance | 30 mg q6 h | 15-30 mg q6 h |
| Elderly / <50 kg | 30 mg | 15 mg |
| Pediatric (2-16 yr) | 1 mg/kg (max 30 mg) single dose | 0.5 mg/kg (max 15 mg) single dose |
| Duration of therapy | Max 5 days combined IM+IV+oral | Same |
| Onset | ~30-45 min | 15-30 min |
| Dilution (IV) | N/A | Give undiluted or dilute in NS; slow IV push over ≥15 sec (or infuse over 15 min for comfort) |
IM loading dose is 60 mg because IM bioavailability is lower than IV. The total course must not exceed 5 days (all routes combined) due to risk of GI ulceration and renal toxicity. - Morgan & Mikhail's Clinical Anesthesiology, 7e; Goodman & Gilman
| Feature | IM | IV |
|---|---|---|
| Dose | 75 mg IM once (deep IM, gluteal) | 75 mg in 250-500 mL NS over 30-120 min |
| Frequency | Once daily (or 75 mg q12h max) | Once or twice; short-term only |
| Duration | Short-term post-op | Same |
| Feature | IM | IV |
|---|---|---|
| Dose | 40 mg loading, then 20-40 mg q6-12 h | Same dose; max 80 mg/day |
| Onset | 7-14 min | Faster |
| Dilution (IV) | N/A | Reconstitute with NS; give as IV bolus |
COX-2 selective - spares gastric mucosa and platelet function, but carries cardiovascular risk. - Miller's Anesthesia, 10e
| Feature | IM | IV |
|---|---|---|
| Route | Not available as IM | Standard 100 mL vial (10 mg/mL = 1000 mg in 100 mL) |
| Adult dose (>50 kg) | - | 1 g q6-8 h; max 4 g/day |
| Adult dose (≤50 kg or <10 yr) | - | 15 mg/kg/dose q6 h; max 75 mg/kg/day |
| Infusion time | - | 15 min IV infusion (do not give as bolus) |
| Onset | - | 5-15 min |
IV acetaminophen (Ofirmev/Paracetamol IV) is infused over 15 minutes. It is not given IM. Oral/rectal acetaminophen is equally effective and far less expensive. - Morgan & Mikhail's Clinical Anesthesiology, 7e
| Feature | IM | IV |
|---|---|---|
| Sub-anesthetic analgesic dose | 0.5-1 mg/kg IM | 0.1-0.35 mg/kg bolus or 5-10 mg IVP once or q2h PRN refractory pain |
| Infusion | - | 0.05-0.35 mg/kg/h (0.83-5.83 mcg/kg/min) |
| Onset | 3-5 min | 1-2 min |
| Dilution (IV bolus) | N/A | Dilute to 1 mg/mL or 2 mg/mL in NS or D5W |
At sub-anesthetic doses, ketamine is a powerful opioid-sparing analgesic with no respiratory depression. Infusion should be on a monitored floor per institution protocol. - Barash Table 55-8
| Principle | Detail |
|---|---|
| IV preferred over IM in hospital | More predictable, titratable, faster onset. IM serum levels vary widely |
| IM discouraged in pediatrics | Painful, fear of needles, variable absorption. IV or regional preferred |
| Never rapid IV bolus | Morphine, fentanyl, tramadol, hydromorphone must be given slowly to avoid respiratory depression, hypotension |
| Ketorolac IM dose > IV | IM 60 mg load vs IV 30 mg load due to bioavailability difference |
| Acetaminophen IV = 15 min infusion | Not a bolus; not available IM |
| Tramadol IV = slow infusion | 100 mg in 100 mL over 15-20 min; rapid IV causes seizures |
| Meperidine/pethidine - avoid | Normeperidine toxicity; not first-line by either route |
| Codeine IV - avoid | Histamine release; cardiovascular instability |
Needle gauge according to age for im
IM injection needle gauge size by age WHO CDC recommendations
IM injection needle gauge length by age
Needle selection for IM injection must be based on: age, sex, weight, injection site, and viscosity of the drug.
| Age Group | Gauge | Needle Length | Preferred Site | Alternate Site |
|---|---|---|---|---|
| Neonate (0-28 days) | 22-25 G | 5/8 inch (16 mm) | Vastus lateralis (anterolateral thigh) | - |
| Infant (1-12 months) | 22-25 G | 1 inch (25 mm) | Vastus lateralis (anterolateral thigh) | - |
| Toddler (1-2 years) | 22-25 G | 1-1.25 inches (25-32 mm) | Vastus lateralis (anterolateral thigh) | Deltoid: 5/8-1 inch (16-25 mm) |
| Child (3-10 years) | 22-25 G | 5/8-1 inch (16-25 mm) deltoid | Deltoid muscle of arm (preferred) | Vastus lateralis: 1-1.25 inches |
| Older child / Adolescent (11-18 years) | 22-25 G | 5/8-1 inch (16-25 mm) | Deltoid muscle of arm (preferred) | Vastus lateralis: 1-1.5 inches |
| Weight | Gauge | Needle Length | Site |
|---|---|---|---|
| < 60 kg (< 130 lbs) | 22-25 G | 1 inch (25 mm) (some experts: 5/8 inch if skin stretched tightly) | Deltoid |
| 60-70 kg (130-152 lbs) | 22-25 G | 1 inch (25 mm) | Deltoid |
| Men: 70-118 kg (152-260 lbs) | 22-25 G | 1-1.5 inches (25-38 mm) | Deltoid |
| Women: 70-90 kg (152-200 lbs) | 22-25 G | 1-1.5 inches (25-38 mm) | Deltoid |
| Men: > 118 kg (> 260 lbs) | 22-25 G | 1.5 inches (38 mm) | Deltoid |
| Women: > 90 kg (> 200 lbs) | 22-25 G | 1.5 inches (38 mm) | Deltoid |
For any adult of any weight using the anterolateral thigh as alternate site: 1-1.5 inches.
| Drug Type | Recommended Gauge |
|---|---|
| Aqueous solutions (vaccines, heparin, most analgesics) | 23-25 G |
| Standard IM drugs (opioids, antibiotics, hormones) | 21-23 G |
| Viscous/oily preparations (depot injections, progesterone in oil, penicillin in oil) | 19-21 G |
| Blood products | 18-20 G |
For analgesics (morphine, ketorolac, tramadol, etc.): 21-23 G is standard in adults; 23-25 G for children and thin patients.
Neonate / Infant (0-12 months)
→ ONLY: Vastus lateralis (anterolateral thigh, middle third)
→ Deltoid NOT used (insufficient muscle mass)
Toddler (1-2 years)
→ Vastus lateralis (PREFERRED)
→ Deltoid acceptable if muscle mass adequate
Children (3-18 years)
→ Deltoid PREFERRED
→ Vastus lateralis as alternate
Adults
→ Deltoid PREFERRED (for most volumes ≤ 2 mL)
→ Ventrogluteal (preferred for volumes > 2 mL, viscous drugs)
→ Dorsogluteal (AVOID - risk of sciatic nerve injury)
| Point | Detail |
|---|---|
| Aspiration | No longer routinely recommended at recommended IM sites (no large vessels present) |
| Injection angle | Always 90 degrees to the skin surface for IM |
| Dorsogluteal site | Avoid - higher risk of sciatic nerve damage, accidental subcutaneous injection (thick fat layer), and suboptimal drug absorption |
| Ventrogluteal site | Preferred for large-volume or viscous IM injections in adults (> 2 mL); free of major nerves and vessels |
| Max volume per site | Infant: 1 mL; Toddler/small child: 1-2 mL; Older child: 2 mL; Adult deltoid: 2-3 mL; Adult ventrogluteal: 3-5 mL |
| Neonates: 5/8" note | Only valid if skin stretched tightly and subcutaneous tissue NOT bunched |
| Obese patients | May require longer needle (up to 2 inches) to reach muscle through subcutaneous fat |